All News
#EULAR2019 session ‘Getting A Grip on The Comorbidities in Gout’ focused on the complex and variable disease profile patients experience and clinicians treat. Do #gout co-morbidities occur in patterns? Dr Ed Roddy discusses. Abstract SP0061 @RheumNow https://t.co/EHoNdP7iMo
Gout Study Group GoutGroup ( View Tweet)
Baracitinib affects JAK2 more than Tofacitinib. Difference can be seen with lower Hb & higher platelets #EULAR2019 https://t.co/BfzuyZI8f9
Dr Irwin Lim _connectedcare ( View Tweet)
JAKi also helps reduce bone loss #EULAR2019 https://t.co/8JOUp3aJWQ
Dr Irwin Lim _connectedcare ( View Tweet)
This graph is a reminder that over time, the level of Inflammation in RA may reduce with lower symptoms. However, CUMULATIVE inflam leads to increasing damage & disability #EULAR2019 https://t.co/ujhODMOp4E
Dr Irwin Lim _connectedcare ( View Tweet)
Look at the difference in patient reported outcome measures. Baracitinib vs Adalimumab #EULAR2019 https://t.co/xrQDdKIspV
Dr Irwin Lim _connectedcare ( View Tweet)
Risk factors for #sarcopenia in #rheumatoid arthritis
👉🏼Male
👉🏼Old age
👉🏼Glucocorticoid
👉🏼Increased MMP3
👉🏼Increased HAQ
#EULAR2019 THU0159
#muscle #RheumatoidArthritis https://t.co/Fn1SvCapqm
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
patients are lucky to have docs like @DrHillaryNorton sharing these #arthritis #breakthroughs #EULAR2019 https://t.co/nQg1WIFD4c
CreakyJoints.org CreakyJoints ( View Tweet)
Optimizing
➡️#weight
➡️sleep
➡️physical #health
➡️emotional health
➡️MTX use
👉🏼may improve persistent #fatigue beyond control of #rheumatoid inflammation
via @Susanbartlett12 #EULAR2019
#obesity https://t.co/vuMNWazloo
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
TNF inhibitors vs JAK inhibitors: what’s the head-to-head study state of play?
(**efficacy not safety, non-real life data of course)
#EULAR2019 Gerd Burmester on ‘The wind of change in RA’ @RheumNow https://t.co/zK1wqskmLc
David Liew drdavidliew ( View Tweet)
AE in SENCIS data. #EULAR2019 Ofev had higher discontinuation due to medication and higher GI associated illness in the trial. https://t.co/0E21Z4B8TU
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
MAXIMISE: rct of secukinumab on axial manifestations of PsA #EULAR2019
Positive as we would expect https://t.co/I1GfxlfWuX
Dr Irwin Lim _connectedcare ( View Tweet)
Burmester on combining TNFi and JAK inhibitors in RA: “I have approached... even companies with both a TNF inhibitor and a JAK inhibitor. I have failed”. Wouldn’t it be interesting to see some data on this? #EULAR2019 @RheumNow
David Liew drdavidliew ( View Tweet)
Solid tumors outcomes in patients with RA treated with #Abatacept - no increase in risk 5.2k in patients over 10years Dra. Teresa Simon #EULAR2019 https://t.co/BIA90SH7qc
Dr.Martínez MtzReuma ( View Tweet)
I am also a big fan of BPs for their durability of treatment effect https://t.co/DKNYboSjdA
Dr Philip Robinson philipcrobinson ( View Tweet)
Gerd Burmester raising some interesting practical questions regarding the use of #biosimilars at #EULAR2019:
How many drugs can a rheumatologist memorize?
How much information material et.c can a rheumatologist store?
How to avoid the ‘#nocebo’ effect when switching?
NatRevRheumatol NatRevRheumatol ( View Tweet)
Cool App called SSDM made by Shanghai group using patient reported data aligned with SLEDAI questions to facilitate pt care, and frequent use of the app correlates well with the attainment of #LLDAS #eular2019 @RheumNow
Alberta Hoi tuna0sashimi ( View Tweet)
Nice work by Mohammad Derakhshan from @iiiglasgow @UofGMVLS https://t.co/ZsCQ5DtAz1
Stefan Siebert StefanSiebert1 ( View Tweet)
In the largest-ever #cohort of inflammatory disease #offspring, very few serious infections in children exposed to #non-TNFi biologics or #tofacitinib were detected #EULAR2019 @carmona_loreto https://t.co/xxbNb5Q2mq
ARD & RMD Open ARD_BMJ ( View Tweet)
Shocking news of increasing mortality rate in SLE over 2000-2015 in Africa and in Asia based on WHO database. GDP per capita matters #eular2019 @RheumNow
Alberta Hoi tuna0sashimi ( View Tweet)
Worldwide Trends in Mortalityof Systemic Lupus Erythematosus : Analysis of the WHO Database
#EULAR2019 https://t.co/pWitNZKgQV
ARD & RMD Open ARD_BMJ ( View Tweet)